Acute Bacterial Rhinosinusitis Decision Tool

Allergy & Otolaryngology, Infectious Disease
No Comments
Loading Add to Favorites
0 votes, average: 0.00 out of 50 votes, average: 0.00 out of 50 votes, average: 0.00 out of 50 votes, average: 0.00 out of 50 votes, average: 0.00 out of 5 (0 votes, average: 0.00)
log on to rate
Loading...
Share
Tweet
Cite
Acute Bacterial Rhinosinusitis Decision Tool
Risk Factors:
[select name="Q1" value="no=0|YES=1"] <-- Signs and symptoms persistent and no improving for 10+ days
[select name="Q2" value="no=0|YES=1"] <-- Severe for 3+ days
[select name="Q3" value="no=0|YES=1"] <-- Worsening or double-sickening 3+ days
[select name="Q4" value="no=0|YES=10"] <-- Risk for resistance (age 65 years, antibiotic use within the past month, prior hospitalization longer than 5 days, comorbidities, or immunocompromised status)
[calc memo="result" value="score=(Q1)+(Q2)+(Q3)+(Q4);score>10?'Symptomatic management AND Second-line antimicrobial therapy':score>1?'Symptomatic management AND First-line antimicrobial therapy':'Symptomatic management'"]
[comment memo="First-line antimicrobial therapy: regular dose amoxicillin/clavulanate. Second-line antimicrobial therapy: high dose amoxicillin/clavulanate; levofloxacin; moxifloxacin (adult); clindamycin AND cefpodoxime OR cefixime; or doxycycline (adult)"]
[html]<hr>[/html][checkbox memo="display/hide references" name="footnotes" value=""][conditional field="footnotes" condition="(footnotes).is('')"][html]
reference: <a href="http://www.ncbi.nlm.nih.gov/pubmed/22438350" target="_blank">Chow AW, Benninger MS, Brook I, Brozek JL, Goldstein EJ, Hicks LA, Pankey GA, Seleznick M, Volturo G, Wald ER, File TM Jr, Infectious Diseases Society of America. IDSA clinical practice guideline for acute bacterial rhinosinusitis in children and adults. Clin Infect Dis. 2012 Apr;54(8):e72-e112.</a>[/html][/conditional]
Acute Bacterial Rhinosinusitis Decision Tool
Risk Factors:
<-- Signs and symptoms persistent and no improving for 10+ days
<-- Severe for 3+ days
<-- Worsening or double-sickening 3+ days
<-- Risk for resistance (age 65 years, antibiotic use within the past month, prior hospitalization longer than 5 days, comorbidities, or immunocompromised status)
resultscore=(Q1)+(Q2)+(Q3)+(Q4);score>10?'Symptomatic management AND Second-line antimicrobial therapy':score>1?'Symptomatic management AND First-line antimicrobial therapy':'Symptomatic management'
First-line antimicrobial therapy: regular dose amoxicillin/clavulanate. Second-line antimicrobial therapy: high dose amoxicillin/clavulanate; levofloxacin; moxifloxacin (adult); clindamycin AND cefpodoxime OR cefixime; or doxycycline (adult)

display/hide references
Result - Copy and paste this output:

Leave a Reply